The p53 breast cancer tissue biomarker in Indian women

Código QR

The p53 breast cancer tissue biomarker in Indian women

Vinayak W Patil1, Mukund B Tayade2, Sangeeta A Pingale1, Shubhangi M Dalvi1, Rajesh B Rajekar1, Hemkant M Deshmukh1, Shital D Patil1, Rajeev Singhai11Department of Biochemistry, 2Department of General Surgery, Grant Medical College and Sir JJ Group of Hospitals, Mumbai, IndiaBackground: Combination...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Patil V, Tayade M, Pingale S, Dalvi S, Rajekar R, Deshmukh H, Patil S, Singhai R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/978c05e2eaf34d86b6a747c5fc8ffe7a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cancer biomarker HER-2/neu in breast cancer in Indian women
por: Singhai R, et al.
Publicado: (2011)

Estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer of Indian women
por: Patil AV, et al.
Publicado: (2011)

Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian women
por: Vinayak W Patil, et al.
Publicado: (2011)

A functionally significant SNP in TP53 and breast cancer risk in African-American women
por: Maureen E. Murphy, et al.
Publicado: (2017)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
por: Wei-Gang Qiu, et al.
Publicado: (2017)

Retraction
por: Singhai R
Publicado: (2012)

Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
por: Eve Merry, et al.
Publicado: (2021)

Gene expression in breast and adipose tissue after 12 months of weight loss and vitamin D supplementation in postmenopausal women
por: Caitlin Mason, et al.
Publicado: (2017)

Role of curcumin in regulating p53 in breast cancer: an overview of the mechanism of action
por: Talib WH, et al.
Publicado: (2018)

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
por: Corey Speers, et al.
Publicado: (2017)

Critical analysis of the potential for microRNA biomarkers in breast cancer management
por: Graveel CR, et al.
Publicado: (2015)

Complexes formed by mutant p53 and their roles in breast cancer
por: Bellazzo A, et al.
Publicado: (2018)

Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
por: Jesmin Akter, et al.
Publicado: (2021)

Tamoxifen for women at high risk of breast cancer
por: Nazarali SA, et al.
Publicado: (2014)

Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study
por: Pascual T, et al.
Publicado: (2012)

p53 e as hemopatias malignas
por: Geraldo Barroso Cavalcanti Júnior, et al.
Publicado: (2002)

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies
por: Nina Radosevic-Robin, et al.
Publicado: (2021)

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
por: Khalid El Bairi, et al.
Publicado: (2021)

Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
por: Luiza N. Weis, et al.
Publicado: (2021)

Management of early breast cancer in older women: from screening to treatment
por: Elomrani F, et al.
Publicado: (2015)

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study
por: Romualdo Barroso-Sousa, et al.
Publicado: (2021)

Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis
por: Martin C. Chang, et al.
Publicado: (2021)

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
por: Vogel VG
Publicado: (2011)

Allostatic load: a framework to understand breast cancer outcomes in Black women
por: Samilia Obeng-Gyasi, et al.
Publicado: (2021)

Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants
por: Matteo Lambertini, et al.
Publicado: (2021)

The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERα) in breast cancer cells
por: Hallman K, et al.
Publicado: (2017)

S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue
por: Sonali Jindal, et al.
Publicado: (2020)

Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer
por: Karama Asleh, et al.
Publicado: (2021)

Disparities in contralateral prophylactic mastectomy use among women with early-stage breast cancer
por: Younji Kim, et al.
Publicado: (2017)

Therapeutic reduction mammoplasty in large-breasted women with cancer using superior and superomedial pedicles
por: Denewer A, et al.
Publicado: (2012)

Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
por: Charlotte Vaysse, et al.
Publicado: (2017)

A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
por: Liang Y, et al.
Publicado: (2018)

Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer
por: Philip D. Poorvu, et al.
Publicado: (2021)

Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer
por: Twelves C, et al.
Publicado: (2011)

Adolescent alcohol, nuts, and fiber: combined effects on benign breast disease risk in young women
por: Catherine S. Berkey, et al.
Publicado: (2020)

Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses
por: Siang-Boon Koh, et al.
Publicado: (2021)

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer
por: Andrea Gombos, et al.
Publicado: (2021)

High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
por: Maria Inasu, et al.
Publicado: (2021)

Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge
por: Grace G. Bushnell, et al.
Publicado: (2021)